Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Company to hold conference call Friday, January 3, 2020 at 8:30 am Eastern TimeFocus of call: top-line efficacy data and sensitivity analyses MORRISVILLE, N.C., Jan. 02, 2020 (GLOBE NEWSWIRE) --...
-
Paula Brown Stafford appointed as CEO effective February 2, 2020G. Kelly Martin’s term as CEO will end on February 1, 2020, per his employment contractMr. Martin will step down from the Novan Board of...
-
A new product candidate, SB207, to target anti-viral opportunitiesPre-IND meeting anticipated in December 2019Development of SB207 to be focused on indications with unmet patient need, such as...
-
MORRISVILLE, N.C., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company’s Phase 2 molluscum study, designed to evaluate topical...
-
Funds to progress women’s health product candidate, WH504Additive to recently announced NIH grant for WH602Women’s health initiative to focus on potential HPV related onco-virus therapeutics ...
-
MORRISVILLE, N.C., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Compensation Committee of Novan’s Board of Directors granted stock...
-
MORRISVILLE, N.C., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has entered into a Common Stock Purchase Agreement (the...
-
Underscores Company’s preparation for potential NDA submission for SB206 in molluscumRole to lead cross-functional coordination of key activities and timelines for the programSB206 top line results...
-
MORRISVILLE, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that it will participate in the H.C. Wainwright 21st Annual Global...
-
Company has received NIH federal grant of approximately $223,000Anticipates additional federal grant of approximately $1.0 millionWomen’s health initiative to focus on potential HPV related onco-virus...